Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
Not yet recruiting
- Conditions
- Anaplastic Thyroid Cancer
- Registration Number
- NCT05819593
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in anaplastic thyroid cancer clinical research, as well as the reasons for withdrawal or discontinuation.
Insights gained from this study will ultimately benefit those with anaplastic thyroid cancer who may be invited to participate in clinical research in the years to come.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Diagnosed with anaplastic thyroid cancer
- Willing to comply with all study related procedures and assessments
- Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
Exclusion Criteria
- No documented diagnosis of anaplastic thyroid cancer
- Any serious and/or unstable pre-existing medical disorders
- Pregnant or lactating woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of anaplastic thyroid cancer patients who decide to enroll in a clinical study 3 months Rate of anaplastic thyroid cancer patients who remain in a clinical study to completion 12 months
- Secondary Outcome Measures
Name Time Method